A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients with Chronic Myelogenous Leukemia. Precision Medicine Communications, [S. l.], v. 2, n. 1, p. 43–58, 2022. DOI: 10.55627/pmc.002.01.0045. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/45. Acesso em: 8 may. 2026.